Monte Rosa Therapeutics, Inc. GLUE Book value per share

Book value per share at other companies

Nurix Therapeutics, Inc.NRIX

$3.62-32.1%

ArvinasARVN

$6.04-33.4%

Kymera TherapeuticsKYMR

$15.37+27.3%

Vor BiopharmaVOR

-$3.50-133%

BiohavenBHVN

$0.88-65.5%

Shattuck Labs, Inc.STTK

$0.85-35.6%

FAQ

What is Monte Rosa Therapeutics, Inc.'s book value per share?

Monte Rosa Therapeutics, Inc. (GLUE) reported book value per share of $4.80 in Q2 2026.

How has Monte Rosa Therapeutics, Inc.'s book value per share changed year-over-year?

Monte Rosa Therapeutics, Inc.'s book value per share increased by 47.2% year-over-year, from $3.26 to $4.80.

What is the long-term trend for Monte Rosa Therapeutics, Inc.'s book value per share?

Over 5 years (2020 to 2025), Monte Rosa Therapeutics, Inc.'s book value per share has grown at a -38.6% compound annual growth rate (CAGR), from -$32.12 to $2.81.

What does book value per share mean?

Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.